AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
The cytoprotective effects of MK-801 and NBQX, selective N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonists, respectively, were compared both singularly and in combination in models of transient severe forebrain and transient focal c...
Main Authors: | Buchan, A, Lesiuk, H, Barnes, K, Li, H, Huang, Z, Smith, K, Xue, D |
---|---|
格式: | Journal article |
语言: | English |
出版: |
1993
|
相似书籍
-
Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
由: Xue, D, et al.
出版: (1994) -
DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
由: Xue, D, et al.
出版: (1992) -
POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
由: Li, H, et al.
出版: (1992) -
The rise and fall of NMDA antagonists for ischemic stroke.
由: Hoyte, L, et al.
出版: (2004) -
NMDA antagonists: their role in neuroprotection.
由: Small, D, et al.
出版: (1997)